“We carry out a lot of research, including on the so-called mass immunity or population immunity. It is already clear that in eight regions of the Russian Federation this population immunity has exceeded 25%, ”Putin said in an interview on the Russia 24 TV channel.

Earlier, the Ministry of Health of Russia issued the N.N. Gamaleya permission to conduct post-marketing studies of the COVID-19 vaccine.

Gunzburg also noted that the civil circulation of the COVID-19 vaccine may begin a month after the start of the third, post-registration stage of drug research.

Virologist, Doctor of Medical Sciences Anatoly Altstein, in an interview with NSN, spoke about possible options for the development of the situation with COVID-19.